Basics Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $928.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.71 | 3.55% Avg Daily Range (30 D): $0.34 | 2.74% Avg Daily Range (90 D): $0.36 | 3.21% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 1,629 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $1.49M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $1.56M Avg Closing Trade (90 D): $1.54M Avg Closing Volume: 105.83K     News Jul 14, 2025 @ 5:00 PM Waldenstrom Macroglobulinemia Market Sees Surging ... Source: Delveinsight Jun 6, 2025 @ 11:00 AM Nurix Therapeutics to Host a Webcast Conference Ca... Source: N/A Jun 2, 2025 @ 12:12 PM Sanofi Expands Rare Immunology Portfolio With Blue... Source: Vandana Singh Apr 28, 2025 @ 8:00 PM Nurix Therapeutics Presents Data at the AACR 2025 ... Source: N/A Apr 8, 2025 @ 8:00 PM Nurix Therapeutics Reports First Quarter 2025 Fina... Source: Nurix Therapeutics, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.52 $-.67 Diluted EPS $-.52 $-.67 Revenue $ $ 44.06M $ 18.45M Gross Profit $ $ $ Net Income / Loss $ $ -43.46M $ -56.35M Operating Income / Loss $ $ -48.32M $ -62.86M Cost of Revenue $ $ $ Net Cash Flow $ $ 8.34M $ -34.08M PE Ratio